Teligent Net Change in Investments - Total 2010-2021 | TLGT

Teligent net change in investments - total from 2010 to 2021. Net change in investments - total can be defined as the total change in long term and short term investments
Teligent Annual Net Change in Investments - Total
(Millions of US $)
2020 $N/A
2019 $N/A
2018 $N/A
2017 $N/A
2016 $N/A
2015 $N/A
2014 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
2009 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.026B 6.88
Dr Reddy's Laboratories (RDY) India $12.104B 21.97
BridgeBio Pharma (BBIO) United States $6.401B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.859B 15.09
Bausch Health Cos (BHC) Canada $1.695B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.191B 7.93
Taysha Gene Therapies (TSHA) United States $0.629B 0.00
Personalis (PSNL) United States $0.438B 0.00
Assembly Biosciences (ASMB) United States $0.111B 0.00
Sol-Gel Technologies (SLGL) Israel $0.022B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00